Monsanto's Roundup Herbicide Study Retracted Due to 'Serious Ethical Concerns'
In a move that has been long overdue, the journal Regulatory Toxicology and Pharmacology has formally retracted a landmark study on the safety of Monsanto's Roundup herbicide, citing "serious ethical concerns." The study, published in 2000, was touted by the company as evidence that its glyphosate-based weed killers posed no health risks to humans. However, internal documents obtained through litigation revealed a far more sinister plot.
It emerged that Monsanto had exerted significant influence over the research paper, which was authored by scientists from outside the company but ultimately benefited from the giant's financial muscle. The study's findings were based on unpublished research provided by Monsanto, and its conclusions were heavily influenced by the company's interests.
The retraction of the study comes after a decade of revelations about Monsanto's tactics in downplaying the risks associated with glyphosate. The company's strategy, dubbed "Freedom to Operate" (FTO), involved paying outside scientists to ghostwrite research papers or provide biased interpretations of existing studies. This practice undermined the integrity of the peer-review process and allowed Monsanto to shape public opinion on its products.
The retraction is a significant blow to the credibility of the scientific community and raises questions about the role of industry influence in shaping research outcomes. It also highlights the need for greater transparency and accountability in the conduct of scientific studies.
Bayer, which acquired Monsanto in 2018, has defended its involvement in the study, claiming that it was adequately disclosed in the acknowledgments section. However, this assertion rings hollow given the scale of the company's influence over the research paper.
The retraction of this study is a long-overdue acknowledgment of the need for greater rigor and transparency in scientific research. As one lawyer involved in the Roundup litigation noted, "This garbage ghostwritten study finally got the fate it deserved." The decision to retract this study marks an important step towards protecting the impartiality of science and ensuring that research outcomes are driven by evidence rather than industry interests.
In a move that has been long overdue, the journal Regulatory Toxicology and Pharmacology has formally retracted a landmark study on the safety of Monsanto's Roundup herbicide, citing "serious ethical concerns." The study, published in 2000, was touted by the company as evidence that its glyphosate-based weed killers posed no health risks to humans. However, internal documents obtained through litigation revealed a far more sinister plot.
It emerged that Monsanto had exerted significant influence over the research paper, which was authored by scientists from outside the company but ultimately benefited from the giant's financial muscle. The study's findings were based on unpublished research provided by Monsanto, and its conclusions were heavily influenced by the company's interests.
The retraction of the study comes after a decade of revelations about Monsanto's tactics in downplaying the risks associated with glyphosate. The company's strategy, dubbed "Freedom to Operate" (FTO), involved paying outside scientists to ghostwrite research papers or provide biased interpretations of existing studies. This practice undermined the integrity of the peer-review process and allowed Monsanto to shape public opinion on its products.
The retraction is a significant blow to the credibility of the scientific community and raises questions about the role of industry influence in shaping research outcomes. It also highlights the need for greater transparency and accountability in the conduct of scientific studies.
Bayer, which acquired Monsanto in 2018, has defended its involvement in the study, claiming that it was adequately disclosed in the acknowledgments section. However, this assertion rings hollow given the scale of the company's influence over the research paper.
The retraction of this study is a long-overdue acknowledgment of the need for greater rigor and transparency in scientific research. As one lawyer involved in the Roundup litigation noted, "This garbage ghostwritten study finally got the fate it deserved." The decision to retract this study marks an important step towards protecting the impartiality of science and ensuring that research outcomes are driven by evidence rather than industry interests.